1. Bannikov, A.V. and Lavrov, A.V., CRISPR/CAS9, the king of genome editing tools, Mol. Biol. (Moscow), 2017, vol. 51, no. 4, pp. 514–525.
2. Baranov, V.S., Molecular medicine: molecular diagnostics, preventive medicine, and gene therapy, Mol. Biol. (Moscow), 2000, vol. 34, no. 4, pp. 590–600.
3. Vetchinova, A.S., Illarioshkin, S.N., Novosadova, E.V., et al., CRISPR/CAS9 artificial nuclease system as a tool for studying monogenic forms of Parkinson’s disease, Sib. Med. Obozr., 2017, no. 4, pp. 53–58.
4. Vetchinova, A.S., Konovalova, E.V., Volchkov, P.Yu., et al., Genome editing on a cellular model of the genetic form of Parkinson’s disease, Geny Kletki, 2016, vol. 9, no. 2, pp. 114–118.
5. Vetchinova, A.S., Konovalova, E.V., Lunev, E.A., and Illarioshkin, S.N., Genome technology editing and its possible use in cell neuroscience, Ann. Nevrol., 2015, vol. 9, no. 4, pp. 59–64.